Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX0CAB
|
||||
| Drug Name |
3-(4-amino-5-(4-methoxyphenyl)furo[2,3-d]pyrimidin-6-yl)benzamide
|
||||
| Synonyms |
CHEMBL363389
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H16N4O3
|
||||
| Canonical SMILES |
COc1ccc(cc1)c2c(oc3ncnc(N)c23)c4cccc(c4)C(=O)N
|
||||
| InChI |
InChI=1S/C20H16N4O3/c1-26-14-7-5-11(6-8-14)15-16-18(21)23-10-24-20(16)27-17(15)12-3-2-4-13(9-12)19(22)25/h2-10H,1H3,(H2,22,25)(H2,21,23,24)
|
||||
| InChIKey |
VRVQOPMRCYIGHU-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.